<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00978705</url>
  </required_header>
  <id_info>
    <org_study_id>MCTT-KRH-06</org_study_id>
    <nct_id>NCT00978705</nct_id>
  </id_info>
  <brief_title>Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood</brief_title>
  <acronym>keratinocyte</acronym>
  <official_title>Clinical Study for Evaluation of Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biosolution Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biosolution Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The efficacy and safety of Autologous cultured keratinocyte cell on severe burn wound.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>November 2007</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <primary_completion_date type="Anticipated">May 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>engraftment assessment</measure>
    <time_frame>4week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the vancouver burn scar scale</measure>
    <time_frame>8, 12, 24 week</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">19</enrollment>
  <condition>Burn Wound</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Autologous cultured keratinocyte cell</intervention_name>
    <description>3x10^7 cell/ vial</description>
    <other_name>Keraheal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age : 1~70 years

          -  More than 30% TBSA of second degree burn or more than 10% TBSA of third degree burn

          -  Must provide signed informed consent prior to participation in any study-related
             procedures

        Exclusion Criteria:

          -  Have a pyogenic infection

          -  Part of the facial cosmetic surgery cost

          -  Hypersensitivity reactions in patients with bovine proteins

          -  Hypersensitivity reactions in patients with Gentamycin

          -  Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wook Chun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hangang Sacred Heart Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hangang Sacred Heart Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>150-030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2009</study_first_submitted>
  <study_first_submitted_qc>September 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2009</study_first_posted>
  <last_update_submitted>September 15, 2009</last_update_submitted>
  <last_update_submitted_qc>September 15, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2009</last_update_posted>
  <responsible_party>
    <name_title>Yunyoung Kim / Senior Research Scientist</name_title>
    <organization>Modern Cell and Tissue Technology</organization>
  </responsible_party>
  <keyword>Keratinocyte Cell</keyword>
  <keyword>severe burn wound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

